T
14.27
-0.40 (-2.73%)
| Penutupan Terdahulu | 14.67 |
| Buka | 14.32 |
| Jumlah Dagangan | 20,708 |
| Purata Dagangan (3B) | 361,157 |
| Modal Pasaran | 266,316,736 |
| Harga / Buku (P/B) | 2.07 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 7 May 2025 - 12 May 2025 |
| EPS Cair (TTM) | -6.83 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 2.35% |
| Nisbah Semasa (MRQ) | 12.65 |
| Aliran Tunai Operasi (OCF TTM) | -59.08 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -65.09 M |
| Pulangan Atas Aset (ROA TTM) | -37.71% |
| Pulangan Atas Ekuiti (ROE TTM) | -84.79% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Tectonic Therapeutic, Inc. | Menaik | - |
AISkor Stockmoo
0.5
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.5 |
| Purata | 0.50 |
|
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 37.73% |
| % Dimiliki oleh Institusi | 43.52% |
| Julat 52 Minggu | ||
| Median | 101.00 (607.78%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Wells Fargo | 21 Mar 2025 | 101.00 (607.78%) | Beli | 21.15 |
| 31 Jan 2025 | 112.00 (684.86%) | Beli | 54.14 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 20 Mar 2025 | Pengumuman | Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights |
| 20 Feb 2025 | Pengumuman | Tectonic Therapeutic to Participate in March Investor Conferences |
| 03 Feb 2025 | Pengumuman | Tectonic Announces $185 Million Private Placement |
| 30 Jan 2025 | Pengumuman | Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |